Loading patent…
AssigneeNitto Boseki Co., Ltd.
InventorsKenta Noda, Toshihide Miura, Humio Nomura, Kazuyuki Sogawa, Mamoru Sato, Hideyuki Yoshitomi, Masaru Miyazaki
Estimating the term…
A marker for detecting pancreatic cancer, said marker comprising a glycoprotein C4BPA or PIGR, whereby a pancreatic cancer patient can be distinguished from a chronic pancreatitis patient or a normal subject and thus specifically diagnosed. Also, the marker is usable in monitoring the postoperative prognosis of a pancreatic cancer patient. When the aforesaid marker is used in combination with another pancreatic cancer marker such as CA19-9, furthermore, a pancreatic cancer patient can be distinguished from a chronic pancreatitis patient or a normal subject and diagnosed more specifically.
A marker for detecting pancreatic cancer, comprising glycoprotein C4BPA or PIGR.
A method for measuring glycoprotein C4BPA or PIGR for detecting pancreatic cancer on the basis of the C4BPA or PIGR contained in a sample.
A method for detecting pancreatic cancer, comprising measuring glycoprotein C4BPA or PIGR contained in a sample and correlating an amount of the C4BPA or PIGR with detection of pancreatic cancer.
Use of glycoprotein C4BPA or PIGR as a marker for detecting pancreatic cancer.
A reagent kit for detecting pancreatic cancer, comprising a reagent for measuring glycoprotein C4BPA or PIGR.
Dependencies are inferred from the claim text.